|
1
|
Dong Y, Yu J and Ng SS: MicroRNA
dysregulation as a prognostic biomarker in colorectal cancer.
Cancer Manag Res. 6:405–422. 2014.PubMed/NCBI
|
|
2
|
Yang Y, Gu X, Zhou M, Xiang J and Chen Z:
Serum microRNAs: A new diagnostic method for colorectal cancer.
Biomed Rep. 1:495–498. 2013.
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liao JM, Zhou X, Zhang Y and Lu H:
MiR-1246: A new link of the p53 family with cancer and Down
syndrome. Cell Cycle. 11:2624–2630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Yao D, Li Y, Chen H, He C, Ding N,
Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression
levels can predict lymph node metastasis in patients with
early-stage cervical squamous cell carcinoma. Int J Mol Med.
32:557–567. 2013.PubMed/NCBI
|
|
7
|
Chen J, Yao D, Zhao S, He C, Ding N, Li L
and Long F: MiR-1246 promotes SiHa cervical cancer cell
proliferation, invasion and migration through suppression of its
target gene thrombospondin 2. Arch Gynecol Obstet. 290:725–732.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takeshita N, Hoshino I, Mori M, Akutsu Y,
Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, et
al: Serum microRNA expression profile: miR-1246 as a novel
diagnostic and prognostic biomarker for oesophageal squamous cell
carcinoma. Br J Cancer. 108:644–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu HL, Wu de P, Wang XF, Wang JG, Jiao F,
Song LL, Xie H, Wen XY, Shan HS, Du YX and Zhao YP: Altered miRNA
expression is associated with differentiation, invasion and
metastasis of esophageal squamous cell carcinoma (ESCC) in patients
from Huaian, China. Cell Biochem Biophys. 67:657–668. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun Z, Meng C, Wang S, Zhou N, Guan M, Bai
C, Lu S, Han Q and Zhao RC: MicroRNA-1246 enhances migration and
invasion through CADM1 in hepatocellular carcinoma. BMC Cancer.
14:6162014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan H, Wang S, Yu H, Zhu J and Chen C:
Molecular pathways and functional analysis of miRNA expression
associated with paclitaxel-induced apoptosis in hepatocellular
carcinoma cells. Pharmacology. 92:167–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Piepoli A, Tavano F, Copetti M, Mazza T,
Palumbo O, Panza A, di Mola FF, Pazienza V, Mazzoccoli G, Biscaglia
G, et al: Mirna expression profiles identify drivers in colorectal
and pancreatic cancers. PloS one. 7:e336632012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Della Vittoria Scarpati G, Calura E, Di
Marino M, Romualdi C, Beltrame L, Malapelle U, Troncone G, De
Stefano A, Pepe S, De Placido S, et al: Analysis of differential
miRNA expression in primary tumor and stroma of colorectal cancer
patients. Biomed Res Int. 2014:8409212014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PloS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamada N, Tsujimura N, Kumazaki M,
Shinohara H, Taniguchi K, Nakagawa Y, Naoe T and Akao Y: Colorectal
cancer cell-derived microvesicles containing microRNA-1246 promote
angiogenesis by activating Smad 1/5/8 signaling elicited by PML
down-regulation in endothelial cells. Biochim Biophys Acta.
1839:1256–1272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zimmermann M, Arachchige-Don AS, Donaldson
MS, Dallapiazza RF, Cowan CE and Horne MC: Elevated cyclin G2
expression intersects with DNA damage checkpoint signaling and is
required for a potent G2/M checkpoint arrest response to
doxorubicin. J Biol Chem. 287:22838–22853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen JQ, Liu CJ, Wen HX, Shi CL, Zhang HS,
Li M and Sun GG: Changes in the expression of cyclin G2 in
esophageal cancer cell and its significance. Tumour Biol.
35:3355–3362. 2014. View Article : Google Scholar
|
|
18
|
Li WJ, Liu GL, Yu F, Xiang XX, Lu YF, Xiao
HZ and Shi YP: CCNG2 suppressor biological effects on thyroid
cancer cell through promotion of CDK2 degradation. Asian Pac J
Cancer Prev. 14:6165–6171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui DW, Cheng YJ, Jing SW and Sun GG:
Effect of cyclin G2 on proliferative ability of prostate cancer
PC-3 cell. Tumour Biol. 35:3017–3024. 2014. View Article : Google Scholar
|
|
20
|
Cui DW, Sun GG and Cheng YJ: Change in
expression of cyclin G2 in kidney cancer cell and its significance.
Tumour Biol. 35:3177–3183. 2014. View Article : Google Scholar
|
|
21
|
Sun GG, Zhang J and Hu WN: CCNG2
expression is down-regulated in colorectal carcinoma and its
clinical significance. Tumour Biol. 35:3339–3346. 2014. View Article : Google Scholar
|
|
22
|
Ye XX, Liu CB, Chen JY, Tao BH and Zhi-Yi
C: The expression of cyclin G in nasopharyngeal carcinoma and its
significance. Clin Exp Med. 12:21–24. 2012. View Article : Google Scholar
|
|
23
|
Xiao X, Zhou L, Cao P, Gong H and Zhang Y:
MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic
role in laryngeal squamous cell carcinoma. Int J Oncol.
46:161–1741. 2015.
|
|
24
|
Hasegawa S, Eguchi H, Nagano H, Konno M,
Tomimaru Y, Wada H, Hama N, Kawamoto K, Kobayashi S, Nishida N, et
al: MicroRNA-1246 expression associated with CCNG2-mediated
chemoresistance and stemness in pancreatic cancer. Br J Cancer.
111:1572–1580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arocho A, Chen B, Ladanyi M and Pan Q:
Validation of the 2-DeltaDeltaCt calculation as an alternate method
of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pigati L, Yaddanapudi SC, Iyengar R, Kim
DJ, Hearn SA, Danforth D, Hastings ML and Duelli DM: Selective
release of microRNA species from normal and malignant mammary
epithelial cells. PloS one. 5:e135152010. View Article : Google Scholar : PubMed/NCBI
|
